These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 26780675)

  • 1. PKPD modelling of PR and QRS intervals in conscious dogs using standard safety pharmacology data.
    Bergenholm L; Collins T; Evans ND; Chappell MJ; Parkinson J
    J Pharmacol Toxicol Methods; 2016; 79():34-44. PubMed ID: 26780675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting QRS and PR interval prolongations in humans using nonclinical data.
    Bergenholm L; Parkinson J; Mettetal J; Evans ND; Chappell MJ; Collins T
    Br J Pharmacol; 2017 Oct; 174(19):3268-3283. PubMed ID: 28675424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic-pharmacodynamic modeling of QRS-prolongation by flecainide: heart rate-dependent effects during sinus rhythm in conscious telemetered dogs.
    Sällström J; Al-Saffar A; Pehrson R
    J Pharmacol Toxicol Methods; 2014; 69(1):24-9. PubMed ID: 24140388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pharmacological characterization of electrocardiogram PR and QRS intervals in conscious telemetered rats.
    Adeyemi O; Parker N; Pointon A; Rolf M
    J Pharmacol Toxicol Methods; 2020; 102():106679. PubMed ID: 32014539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Telemetered common marmosets is useful for the assessment of electrocardiogram parameters changes induced by multiple cardiac ion channel inhibitors.
    Watanabe K; Tsubouchi T; Yamada T; Hinoi E; Miyawaki I
    J Toxicol Sci; 2019; 44(7):441-457. PubMed ID: 31270301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detecting drug-induced prolongation of the QRS complex: new insights for cardiac safety assessment.
    Cros C; Skinner M; Moors J; Lainee P; Valentin JP
    Toxicol Appl Pharmacol; 2012 Dec; 265(2):200-8. PubMed ID: 23073507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the QT interval response during sinus and paced rhythm in conscious and anesthetized beagle dogs.
    Ollerstam A; Visser SA; Duker G; Forsberg T; Persson AH; Nilsson LB; Björkman JA; Gabrielsson J; Al-Saffar A
    J Pharmacol Toxicol Methods; 2007; 56(2):131-44. PubMed ID: 17689270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ECG telemetry in conscious guinea pigs.
    Ruppert S; Vormberge T; Igl BW; Hoffmann M
    J Pharmacol Toxicol Methods; 2016; 81():88-98. PubMed ID: 27118261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of flecainide and quinidine on arrhythmogenic properties of Scn5a+/Delta murine hearts modelling long QT syndrome 3.
    Stokoe KS; Thomas G; Goddard CA; Colledge WH; Grace AA; Huang CL
    J Physiol; 2007 Jan; 578(Pt 1):69-84. PubMed ID: 17023504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pharmacokinetic-pharmacodynamic model for cardiovascular safety assessment of R1551.
    Fleury A; Lavé T; Jonsson F; Schmitt M; Hirkaler G; Polonchuk L; Breidenbach A
    J Pharmacol Toxicol Methods; 2011; 63(1):123-33. PubMed ID: 20732434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-invasive telemetric electrocardiogram assessment in conscious beagle dogs.
    Prior H; McMahon N; Schofield J; Valentin JP
    J Pharmacol Toxicol Methods; 2009; 60(2):167-73. PubMed ID: 19539041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Translation of flecainide- and mexiletine-induced cardiac sodium channel inhibition and ventricular conduction slowing from nonclinical models to clinical.
    Heath BM; Cui Y; Worton S; Lawton B; Ward G; Ballini E; Doe CP; Ellis C; Patel BA; McMahon NC
    J Pharmacol Toxicol Methods; 2011; 63(3):258-68. PubMed ID: 21194571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological characterisation of electrocardiogram J-T
    Nogawa H; Muraki Y; Kawai T; Kuninishi Y
    Eur J Pharmacol; 2022 Jul; 927():175065. PubMed ID: 35640715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calculation of QT shift in non clinical safety pharmacology studies.
    Champeroux P; Martel E; Fowler JS; Maurin A; Sola ML; Jude S; Elamrani F; Weyn AA; Laveissiere A; Lala P; Richard S
    J Pharmacol Toxicol Methods; 2009; 59(2):73-85. PubMed ID: 19135537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arrhythmogenic activities of antiarrhythmic drugs in conscious hypokalemic dogs with atrioventricular block: comparison between quinidine, lidocaine, flecainide, propranolol and sotalol.
    Weissenburger J; Davy JM; Chézalviel F; Ertzbischoff O; Poirier JM; Engel F; Lainée P; Penin E; Motté G; Cheymol G
    J Pharmacol Exp Ther; 1991 Nov; 259(2):871-83. PubMed ID: 1941633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term stability, reproducibility, and statistical sensitivity of a telemetry-instrumented dog model: A 27-month longitudinal assessment.
    Fryer RM; Ng KJ; Chi L; Jin X; Reinhart GA
    J Pharmacol Toxicol Methods; 2015; 74():26-32. PubMed ID: 25946685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessments of the QT/QRS restitution in perfused guinea-pig heart can discriminate safe and arrhythmogenic drugs.
    Osadchii OE
    J Pharmacol Toxicol Methods; 2017 Sep; 87():27-37. PubMed ID: 28552278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Model-based evaluation of drug-induced QTc prolongation for compounds in early development.
    Dubois VF; Yu H; Danhof M; Della Pasqua O;
    Br J Clin Pharmacol; 2015 Jan; 79(1):148-61. PubMed ID: 25099645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic-pharmacodynamic modeling of drug-induced effect on the QT interval in conscious telemetered dogs.
    Ollerstam A; Visser SA; Persson AH; Eklund G; Nilsson LB; Forsberg T; Wiklund SJ; Gabrielsson J; Duker G; Al-Saffar A
    J Pharmacol Toxicol Methods; 2006; 53(2):174-83. PubMed ID: 16140023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The anesthetized guinea pig: an effective early cardiovascular derisking and lead optimization model.
    Morissette P; Nishida M; Trepakova E; Imredy J; Lagrutta A; Chaves A; Hoagland K; Hoe CM; Zrada MM; Travis JJ; Zingaro GJ; Gerenser P; Friedrichs G; Salata JJ
    J Pharmacol Toxicol Methods; 2013; 68(1):137-49. PubMed ID: 23649000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.